Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide

Abaloparatide (ABL) is a 34-amino acid peptide designed to be a selective activator of the parathyroid hormone receptor type 1 signaling pathway. In the Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE), subcutaneous ABL reduced the risk of new vertebral, nonvertebral, clinical, and maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Reginster, Jean-Yves, Hattersley, Gary, Williams, Gregory C., Hu, Ming-yi, Fitzpatrick, Lorraine A., Lewiecki, E. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182596/
https://www.ncbi.nlm.nih.gov/pubmed/29951742
http://dx.doi.org/10.1007/s00223-018-0450-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182596/
https://www.ncbi.nlm.nih.gov/pubmed/29951742
http://dx.doi.org/10.1007/s00223-018-0450-0

Ejemplares similares